99mTc-glycopeptide: Synthesis, biodistribution and imaging in breast tumor-bearing rodents

Applied Radiation and Isotopes

Volumn 66, Issue 3, 2008, Pages 320-331

  Wei, I Chien ^a   Tsao, Ning ^b   Huang, Ya Hui ^a   Ho, Yen Sheng ^a   Wu, Chung Chin ^a   Yu, Dong Fang ^b   Yang, David J ^b  

^a Innovation Development Center   (Taiwan)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biodistribution; Glycopeptide; Imaging; Radiolabeled

Indexed keywords

BIODISTRIBUTION; GLYCOPEPTIDES; IN VITRO STUDIES; PACLITAXEL TREATMENT; PLANAR IMAGING;

BIOSYNTHESIS; CAPILLARY ELECTROPHORESIS; COUPLING AGENTS; GLYCOPROTEINS; MEDICAL IMAGING; TUMORS;

PEPTIDES;

ANTINEOPLASTIC AGENT; ASPARTIC ACID; CHITOSAN; CYANAMIDE; DRUG CARRIER; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; GLYCOPEPTIDE TC 99M; PACLITAXEL; PERTECHNETIC ACID TC 99M; RHENIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CAPILLARY ELECTROPHORESIS; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOSOL; DRUG BINDING SITE; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; FISCHER 344 RAT; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; RODENT; SINGLE DRUG DOSE;

ANIMALS; AREA UNDER CURVE; CELL LINE, TUMOR; FEMALE; GLYCOPEPTIDES; ISOTOPE LABELING; MAMMARY NEOPLASMS, EXPERIMENTAL; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RATS; RATS, INBRED F344; SCINTILLATION COUNTING; TISSUE DISTRIBUTION;

EID: 38349103087     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2007.10.002     Document Type: Article

References (30)

1. 99mTc-DTPA brain scintigraphy. Acta Neurochir. (Wien) 138 (1996) 1179-1185
2. Behe M., Kluge G., Becker W., Gotthardt M., and Behr T.M. Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys. J. Nucl. Med. 46 (2005) 1012-1015
3. Bereau V.M., Khan S.I., and Abu-Omar M.M. Synthesis of enantiopure oxorhenium(V) and arylimidorhenium(V) "3+2" Schiff base complexes. X-ray diffraction, cyclic voltammetry, UV-vis, and circular dichroism characterizations. Inorg. Chem. 40 (2001) 6767-6773
4. Bernkop-Schnurch A., Hornof M., and Guggi D. Thiolated chitosans. Eur. J. Pharm. Biopharm. 57 (2004) 9-17
5. Biagini G., Pugnaloni A., Damadei A., Bertani A., Belligolli A., Bicchiega V., and Muzzarelli R. Morphological study of the capsular organization around tissue expanders coated with N-carboxybutyl chitosan. Biomaterials 12 (1991) 287-291
6. Chenu C., Serre C.M., Raynal C., Burt-Pichat B., and Delmas P.D. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone 22 (1998) 295-299
7. Fujita M., Ishihara M., Morimoto Y., Simizu M., Saito Y., Yura H., Matsui T., Takase B., Hattori H., Kanatani Y., Kikuchi M., and Maehara T. Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction. J. Surg. Res. 126 (2005) 27-33
8. 186Re(V)-DMS. Nucl. Med. Biol. 26 (1999) 771-779
9. 99m-DTPA renography, predicted creatinine clearance method and plasma sample method. Ann. Nucl. Med. 17 (2003) 561-565
10. Kato Y., Onishi H., and Machida Y. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr. Pharm. Biotechnol. 4 (2003) 303-309
11. Koppe M.J., Bleichrodt R.P., Soede A.C., Verhofstad A.A., Goldenberg D.M., Oyen W.J., and Boerman O.C. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin. J. Nucl. Med. 45 (2004) 1224-1232
12. Lai C.S., Froncisz W., and Hopwood L.E. An evaluation of paramagnetic broadening agents for spin probe studies of intact mammalian cells. Biophys. J. 52 (1987) 625-628
13. Li W.P., Lewis J.S., Kim J., Bugaj J.E., Johnson M.A., Erion J.L., and Anderson C.J. DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjugate Chem. 13 (2002) 721-728
14. 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting. Appl. Radiat. Isot. 64 (2006) 971-978
15. Lu Z.R., Wang X., Parker D.L., Goodrich K.C., and Buswell H.R. Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging. Bioconjugate Chem. 14 (2003) 715-719
16. Pieper J.S., van Wachem P.B., van Luyn M.J.A., Brouwer L.A., Hafmans T., Veerkamp J.H., and van Kuppevelt T.H. Attachment of glycosaminoglycans to collagenous matrices modulates the tissue response in rats. Biomaterials 21 (2000) 1689-1699
17. Polykratis A., Katsoris P., Courty J., and Papadimitriou E. Characterization of heparin affinity regulatory peptide signaling in human endothelial cells. J. Biol. Chem. 280 (2005) 22454-22461
18. Prabaharan M., and Mano J.F. Chitosan-based particles as controlled drug delivery systems. Drug Deliv. 12 (2005) 41-57
19. Reiman R.E., Benua R.S., Gelbard A.S., Allen J.C., Vomero J.J., and Laughlin J.S. Imaging of brain tumors after administration of l-(N-13)glutamate: concise communication. J. Nucl. Med. 23 (1982) 682-687
20. Rijpkema M., Schuuring J., Bernsen P.L., Bernsen H.J., Kaanders J.H., van der Kogel A.J., and Heerschap A. BOLD MRI response to hypercapnic hyperoxia in patients with meningiomas: correlation with gadolinium-DTPA uptake rate. Magn. Reson. Imaging 22 (2004) 761-767
21. 99m-HSA-D. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90 (2000) 525-537
22. Stabin M. MIRDOSE: the personal computer software for use in internal dose assessment in nuclear medicine. J. Nucl. Med. 37 (1996) 538-546
23. Tansey W., Ke S., Cao X.Y., Pasuelo M.J., Wallace S., and Li C. Synthesis and characterization of branched poly(l-glutamic acid) as a biodegradable drug carrier. J. Control Release 94 (2004) 39-51
24. 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical. Nucl. Med. Biol. 29 (2002) 569-573
25. Tzanopoulou S., Pirmettis I.C., Patsis G., Raptopoulou C., Terzis A., Papadopoulos M., and Pelecanou M. Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives. Inorg. Chem. 45 (2006) 902-909
26. Veronese M.L., Flaherty K., Kramer A., Konkle B.A., Morgan M., Stevenson J.P., and O'Dwyer P.J. Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors. Cancer Chemother. Pharmacol. 55 (2005) 497-501
27. Wang L.Y., Ma G.H., and Su Z.G. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug. J. Control Release 106 (2005) 62-75
28. Waniewski R.A., and Martin D.L. Characterization of l-glutamic acid transport by glioma cells in culture: evidence for sodium-independent, chloride-dependent high affinity influx. J. Neurosci. 4 (1984) 2234-2237
29. Yang D.J., Li C., Nikiforow S., Gretzer M.B., Kuang L.R., Lopez M.S., Vargas K., and Wallace S. Diagnostic and therapeutic potential of poly(benzyl l-glutamate). J. Pharm. Sci. 83 (1994) 328-331
30. 99mTc-EC- annexin V. Cancer Biother. Radiopharm. 16 (2001) 73-84